ViroPharma Prescribes $8M To Cure Investor Suit
By Alex Wolf ( April 30, 2015, 1:55 PM EDT) -- A class of ViroPharma Inc. shareholders claiming the company intentionally misled investors regarding market exclusivity for its signature gastrointestinal antibiotic asked a Pennsylvania federal judge Wednesday to approve an $8 million settlement reached through mediation, saying continued litigation could reduce or eliminate future recovery....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.